Acetaminophen Recruiting Phase 1 Trials for Graft Versus Host Disease (GVHD) / Sickle Cell Disorders Treatment

Indications	Status	Purpose	Phase
DBCOND0051557 (Graft Versus Host Disease (GVHD)) DBCOND0051876 (Sickle Cell Disorders)	Recruiting	Treatment	1

clinicaltrials.gov Identifier	Title	Drugs
NCT02867800	Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease	Abatacept (DB01281) Acetaminophen (DB00316) Alemtuzumab (DB00087) Antithymocyte immunoglobulin (rabbit) (DB00098) Cyclosporine (DB00091) Diphenhydramine (DB01075) Fludarabine (DB01073) Melphalan (DB01042) Meperidine (DB00454) Methotrexate (DB00563) Methylprednisolone (DB00959) Mycophenolate mofetil (DB00688) Sirolimus (DB00877) Tacrolimus (DB00864) Thiotepa (DB04572)